Photoacoustics technique detects small number of cancer cells

Researchers have developed multiple techniques and procedures to detect cancer cells during the earliest stages of the disease or after treatment. But one of the major limitations of these technologies is their inability to detect the presence of only a few cancer cells.

Now, a research collaboration between the University of Missouri-Columbia and Mexico's Universidad de Guanajuato shows that pulsed photoacoustic techniques, which combine the high optical contrast of with the high resolution of ultrasound, can do just that, in vitro. Most are naturally elusive, so they used a photoacoustic enhancer to detect them.

New developments are necessary, the researchers say, to be able to properly use photoacoustic techniques to recognize different cancer cell types inside the human body or in blood or tissue samples.

More information: "An experimental and theoretical approach to the study of the photoacoustic signal produced by cancer cells" is published in AIP Advances.

Related Stories

Gold Nanobeacons Detect Sentinel Lymph Nodes

date Mar 25, 2010

(PhysOrg.com) -- Virtually every patient diagnosed with breast cancer or melanoma undergoes lymph node biopsy to determine if their cancer has begun spreading in the body. Taking this biopsy involves an invasive and uncomfortable ...

Nanoparticles Detect and Purge Metastases in Lymph Nodes

date Oct 30, 2009

Colonoscopy represents one of the great weapons against cancer. In one step, a physician can find precancerous lesions in the colon and then cut them out, an on-the-spot intervention that prevents cancer from developing. ...

Recommended for you

Using healthy skin to identify cancer's origins

date 16 hours ago

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and de ...

Gender differences in receipt of end-of-life care

date 16 hours ago

(HealthDay)—There are gender differences in receipt of end-of-life (EoL) care among terminally ill cancer patients, with male patients more likely to receive intensive care unit (ICU) care, according to ...

Scientists unveil prostate cancer's 'Rosetta Stone'

date 18 hours ago

Almost 90 per cent of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs, a landmark new study reveals.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.